Scientists identify factor that may trigger type 1 diabetes

February 11, 2016

A team of researchers, led by investigators at the University of Colorado School of Medicine, have identified a new class of antigens that may be a contributing factor to type 1 diabetes, according to an article published in the current issue of the journal Science.

In autoimmune disease, the key question is why the immune system attacks the body's own tissues. Type 1 diabetes is the autoimmune form of diabetes, in which insulin-producing beta in the pancreas are destroyed by , especially those known as T cells. Insulin is the hormone that regulates levels of glucose in the blood and without insulin, a life-threatening disease results. Currently, there is no cure for type 1 diabetes.

"Our lab studies the type of T cell known as a CD4 T cell," said Kathryn Haskins, PhD, professor of immunology and microbiology and corresponding author of the article. "We have focused on autoreactive CD4 T cells using a mouse model of autoimmune diabetes. We have been especially interested in identifying the antigens that activate these T cells."

Antigens for T cells are pieces of proteins, or protein fragments (peptides) that have to be taken up and presented to the T cells by . Normally, a CD4 T cell is supposed to respond to "foreign" antigens, like a viral peptide. But in autoimmune disease the T cells respond to antigens that are generated in the body. Such proteins and peptides are called autoantigens.

When an autoreactive T cell sees its antigen, it becomes activated and can initiate disease. By identifying those antigens, scientists may be able to use that information to detect autoreactive T cells early in disease, or better yet, in at-risk individuals. If they are able to use the antigens to turn off destructive T cells, they may be able to prevent the disease.

Haskins and others, including fellow corresponding author Thomas Delong, PhD, assistant professor of immunology and microbiology, conducted experiments to analyze the fractions of that contain antigen for autoreactive CD4 T cells in order to identify autoantigens in type 1 diabetes. They discovered a new class of that consist of insulin fragments fused to peptides of other proteins present in beta cells. That fusion leads to generation of hybrid insulin peptides that are not encoded in an individual's genome.

If peptides in the body are modified from their original form, they essentially become "foreign" to the immune system and this may explain why they become targets for the autoreactive T cells. The discovery of hybrid peptides as targets of the immune system provides a plausible explanation of how the is tricked into destroying the body's own beta cells. The discovery may also lead to a better understanding of other .

Explore further: Antibodies reverse type 1 diabetes in new immunotherapy study

More information: "Pathogenic CD4 T cells in type 1 diabetes recognize epitopes formed by peptide fusion," by T. Delong et al. science.sciencemag.org/cgi/doi/10.1126/science.aad2791

Related Stories

Researchers prevent type 1 diabetes in lab

January 20, 2015

In new research published in Endocrinology, Thomas Burris, Ph.D., chair of pharmacological and physiological science at Saint Louis University, reports that his team has found a way to prevent type I diabetes in an animal ...

Type 2 diabetes drug can exhaust insulin-producing cells

February 11, 2016

Long-term use of liraglutide, a substance that helps to lower blood sugar levels in patients with type 2 diabetes, can have a deteriorating effect on insulin-producing beta cells, leading to an increase in blood sugar levels. ...

Recommended for you

Do germs cause type 1 diabetes?

May 16, 2016

Germs could play a role in the development of type 1 diabetes by triggering the body's immune system to destroy the cells that produce insulin, new research suggests.

Melatonin signaling is a risk factor for type 2 diabetes

May 12, 2016

A sleeping pancreas releases less insulin, but how much insulin drops each night may differ from person to person, suggests a study published May 12, 2016 in Cell Metabolism. Up to 30 percent of the population may be predisposed ...

New gene for familial high cholesterol

May 12, 2016

New research from Denmark reveals the gene that explains one quarter of all familial hypercholesterolemia with very high blood cholesterol. Familial hypercholesterolemia is the most common genetic disorder leading to premature ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.